Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 17, 2018Biology of Blood and Marrow TransplantationOpen Access

Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSalyka SengsayadethVA Tennessee Valley Healthcare SystemMLMyriam LabopinInsermABAriane BoumendilSorbonne Université

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sengsayadeth et al. (2018) studied this question.

synapsesocial.com/papers/6a7154dc26a7f98052ddb3b3https://doi.org/10.1016/j.bbmt.2018.04.008
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors2013 · 251 citations
  2. 2Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic Stem Cell Transplantation2013 · 87 citations
  3. 3Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as “AML not otherwise specified” (AML-NOS) or “AML with myelodysplasia-related changes” (AML-MRC)2010 · 128 citations
  4. 4Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia2009 · 30 citations
  5. 5Predictive factors for latency period and a prognostic model for survival in patients with therapy‐related acute myeloid leukemia2013 · 41 citations